Carolin Anita Keßler on LinkedIn: Zielgenaue Krebstherapien: Roche-Tochter Foundation Medicine ausgezeichnet…
![Roche launches FDA-approved diagnostic test for personalised cancer care in Singapore | MobiHealthNews Roche launches FDA-approved diagnostic test for personalised cancer care in Singapore | MobiHealthNews](https://www.mobihealthnews.com/sites/default/files/F1CDx-Kit_Mobi.jpg)
Roche launches FDA-approved diagnostic test for personalised cancer care in Singapore | MobiHealthNews
![Roche spent $1B for the Leading Molecular Information Biotech company: Foundation Medicine - Labiotech.eu Roche spent $1B for the Leading Molecular Information Biotech company: Foundation Medicine - Labiotech.eu](https://www.labiotech.eu/wp-content/uploads/2015/01/Roche-lab.jpg)
Roche spent $1B for the Leading Molecular Information Biotech company: Foundation Medicine - Labiotech.eu
![Foundation Medicine and Chugai Announce Partnership with National Cancer Center for the Use of FoundationOne®Liquid in the Third Stage of SCRUM-Japan | Business Wire Foundation Medicine and Chugai Announce Partnership with National Cancer Center for the Use of FoundationOne®Liquid in the Third Stage of SCRUM-Japan | Business Wire](https://mms.businesswire.com/media/20200212005980/en/773224/5/FMI_vertical-slate.jpg)
Foundation Medicine and Chugai Announce Partnership with National Cancer Center for the Use of FoundationOne®Liquid in the Third Stage of SCRUM-Japan | Business Wire
![Point32Health and Foundation Medicine Expand Access to Comprehensive Genomic Profiling for Members with Advanced Cancer | Business Wire Point32Health and Foundation Medicine Expand Access to Comprehensive Genomic Profiling for Members with Advanced Cancer | Business Wire](https://mms.businesswire.com/media/20230302005150/en/1727718/23/Foundationmedicine_p32h_logo_v2.jpg)
Point32Health and Foundation Medicine Expand Access to Comprehensive Genomic Profiling for Members with Advanced Cancer | Business Wire
![Roche France, Foundation Medicine and the Institute Gustave Roussy announce unique partnership to provide in-house liquid biopsy genomic testing to cancer patients in France | Gustave Roussy Roche France, Foundation Medicine and the Institute Gustave Roussy announce unique partnership to provide in-house liquid biopsy genomic testing to cancer patients in France | Gustave Roussy](https://www.gustaveroussy.fr/sites/default/files/cppartenariat-fresh-share-180923.png)